Headache is also reported as an adverse effect in clinical trials of tirzepatide and other drugs in this class, such as semaglutide products (Ozempic and Wegovy) and liraglutide brands (like Saxenda), but individual responses vary
The drug, called bofanglutide , is being developed by Gan & Lee Pharmaceuticals, a Beijing-based company, and the trial results were published June 30, 2026 in Annals of Internal Medicine
It supports fat loss by enhancing fat oxidation, preserving lean muscle mass, and speeding up recovery due to its rapid action
Some anxiety medications, including certain SSRIs and SNRIs, may trigger palpitations , especially during dose changes
No significant metabolic contraindications: Active malignancy, uncontrolled insulin resistance, or significant thyroid disease can alter both the risk-benefit calculation and the expected response